0001493152-22-000113.txt : 20220103
0001493152-22-000113.hdr.sgml : 20220103
20220103161550
ACCESSION NUMBER: 0001493152-22-000113
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211229
FILED AS OF DATE: 20220103
DATE AS OF CHANGE: 20220103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lisi Steven A.
CENTRAL INDEX KEY: 0001702628
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38892
FILM NUMBER: 22502282
MAIL ADDRESS:
STREET 1: 2 ILAN RAMON, SCIENCE PARK
CITY: NESS ZIONA
STATE: L3
ZIP: 7403635
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Beyond Air, Inc.
CENTRAL INDEX KEY: 0001641631
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 473812456
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 825 EAST GATE BOULEVARD, SUITE 320
CITY: GARDEN CITY
STATE: NY
ZIP: 11530
BUSINESS PHONE: 516-665-8200
MAIL ADDRESS:
STREET 1: 825 EAST GATE BOULEVARD, SUITE 320
CITY: GARDEN CITY
STATE: NY
ZIP: 11530
FORMER COMPANY:
FORMER CONFORMED NAME: AIT Therapeutics, Inc.
DATE OF NAME CHANGE: 20170117
FORMER COMPANY:
FORMER CONFORMED NAME: KokiCare, Inc.
DATE OF NAME CHANGE: 20150507
4
1
ownership.xml
X0306
4
2021-12-29
0
0001641631
Beyond Air, Inc.
XAIR
0001702628
Lisi Steven A.
C/O BEYOND AIR, INC.
900 STEWART AVENUE, SUITE 301
GARDEN CITY
NY
11530
1
1
0
0
CEO and Chairman of the Board
Common Stock
2021-12-29
4
S
0
21376
9.532
D
1150111
D
The sales reported on this Form 4 represent shares of common stock of Beyond Air, Inc. (the "Company") sold by the reporting person to cover tax withholding obligations in connection with the vesting of previously granted restricted stock units. The reporting person's sale of the Company's common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 21,376 shares, with the reporting person's purchase of 25,000 shares of the Company's common stock at a weighted average price of $7.85 per share on August 13, 2021. The reporting person has paid to the Company, and the Company has received, $37,675, representing the full amount of the profit realized in connection with the short-swing transaction.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.40 to $9.70, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
/s/ Steven A. Lisi
2022-01-03